SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-106757
Filing Date
2019-04-15
Accepted
2019-04-15 17:30:02
Documents
2
Period of Report
2019-04-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d696673d8k.htm 8-K 18815
2 EX-99.1 d696673dex991.htm EX-99.1 8429
  Complete submission text file 0001193125-19-106757.txt   28495
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13467 | Film No.: 19749367
SIC: 8731 Services-Commercial Physical & Biological Research